April Zambelli-Weiner

TTi Health Research & Economics

April Zambelli-Weiner

From her LinkedIn:

My #1 priority is to leave the world better than I found it.

Throughout my career as a Hopkins-trained epidemiologist and healthcare business innovator and entrepreneur, I’ve always had my eye and my heart on the world’s most marginalized and underserved populations. My primary motivator has never been the prestige of being a Johns Hopkins scientist. It has always been patient advocacy. Working to influence healthcare policy and navigating companies with promising research and medical technologies through this complex marketplace can transform healthcare from the top down and the bottom up.

In this industry, what I often see is a disconnect between innovation and our highly regulated medical landscape. My team and I work to bridge this gap, to help MedTech companies understand how to navigate the complex healthcare landscape with integrity so they can not only bring true innovation to the market but can also operate across the entire business lifecycle.

I bring a unique combination of expertise and experience as both an executive and a scientist with 20+ years of leading and executing real-world evidence strategy, evidence generation, clinical-economic studies, analytics, post-market study design, and value communication. The breadth and depth of my journey has given me a comprehensive integrated view of the marketplace as I work to bridge the gaps that hinder healthcare innovation from reaching patients.

I believe in maximizing the micro-opportunities of addressing humanity’s rarest diseases – which impact only 1% of the population – with new research and emerging medical technologies. As a family member and caregiver of patients with rare congenital defects, I am personally vested in changing the hierarchical model of healthcare to place the patient and the provider back at the center. My success in designing studies that impact policy change is a value-add to companies pursuing opportunities to enter the market.